Similar Papers

Paper Title
Journal
Date
Author
Unsealed Source: Scope of Practice for Radiopharmaceuticals Among United States Radiation Oncologists
Utkarsh Shukla ... Mudit Chowdhary
Advances in Radiation Oncology | VOL. 7
Utkarsh Shukla, et. al.Utkarsh Shukla ... Mudit Chowdhary
26 Oct 2021
Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer.
Milan Grkovski ... Brandon S Imber
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. 64
Milan Grkovski, et. al.Milan Grkovski ... Brandon S Imber
31 Aug 2023
A Treatment Planning Method for Sequentially Combining Radiopharmaceutical Therapy and External Radiation Therapy
Robert F Hobbs ... George Sgouros
International Journal of Radiation Oncology*Biology*Physics | VOL. 80
Robert F Hobbs, et. al.Robert F Hobbs ... George Sgouros
13 Oct 2010
A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy: An ASTRO Consensus Document
John M Buatti ... Neeta Pandit-Taskar
International Journal of Radiation Oncology*Biology*Physics | VOL. 109
John M Buatti, et. al.John M Buatti ... Neeta Pandit-Taskar
26 Nov 2020
View more papers

More From: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Paper Title
Journal
Date
Author
Reflections on the Demand for PSMA- and SSTR-Targeted Radiopharmaceutical Therapies: Why We Were Wrong (and Why We Will Be Right Eventually).
Johannes Czernin ... Jeremie Calais
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Johannes Czernin, et. al.Johannes Czernin ... Jeremie Calais
06 Feb 2025
177Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer.
Huan Du ... Xiaobo Du
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Huan Du, et. al.Huan Du ... Xiaobo Du
06 Feb 2025
Safety, Dosimetry, and Feasibility of [68Ga]Ga-PSMA-R2 as an Imaging Agent in Patients with Biochemical Recurrence or Metastatic Prostate Cancer.
Liza Lindenberg ... Lilja B Solnes
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Liza Lindenberg, et. al.Liza Lindenberg ... Lilja B Solnes
06 Feb 2025
Exploring the Flare Phenomenon in Patients with Castration-Resistant Prostate Cancer: Enzalutamide-Induced PSMA Upregulation Observed on PSMA PET.
Suzanne Van Der Gaag ... Daniela E Oprea-Lager
Journal of nuclear medicine : official publication, Society of Nuclear Medicine | VOL. -
Suzanne Van Der Gaag, et. al.Suzanne Van Der Gaag ... Daniela E Oprea-Lager
06 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.